Vol. 161, No. 2, 1989
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 776-781
June 15. 1989
HIGH
AND
LOW AFFINITY
F.
Badr*,
Karen
Kamal
Departments
Received
of
April
28,
renal
described
signal
transduction
marked and,
intravenous
infusion
alkalinization
rat peptide
these
*
correspondence
Abbreviations Endothelin: angiotensin (1,4,5)-trisphosphate:
Mindy
School
used atria1 A II;
cells
confirmed the the in
should in
this natriuretic intracellular InsPj.
0006-291x/89 $1.50 Copyright 0 1989 by Academic Press, Inc. All rights of reproduction in any form reserved.
which
of
responses
in
by
(2).
others
presence
present
of studies,
likely
mechanism
result
induce
rat
from
actions receptors
examined
its
intracellular
mesangial
These
specific we
in
ultrafiltration
which to
the
increases
capillary
found
through
concentrations.
the
rate was
cells
calcium is
renal
increases
include
free
glomerular
ET
and
Endothelin
mesangial
filtration
mitogenic
In
mesangial
ET; II:
the
addition,
been
cells.
to
whom
In
(1).
contraction
in
suggested
[1251]-ET
To
RAT
Snajdar,
glomerular,
kidney
and
cell
provoke since
cells
on
M.
University
cell,
rat glomerular
glomerular (1).
has
mesangial
Vanderbilt 37232-2312
pathways
reductions hence,
and which
the
contracts
mesangial the
in
trisphosphate
Endothelin-induced
finding
ET
and
coefficient
TN
mesangial
to
inositol
mediating
Sugiura, Rudolf Tadashi Inagami
Biochemistry, Nashville,
resistance of
activation intracellular
ON CULTURED
glomerular mesangial cells, thereby influencing filtration rate. Here, we demonstrate the presence of two sites on cultured rat mesangial cells with Kds of 0.76 and binding capacity (Bmax) values of 6.78~10~ and 27.60~10~ respectively. Binding of [12sI]-ET was maximal at 120 min the subsequent60 min, and selective. No competition for with >lOOO-fold concentrations of atria1 natriuretic II, arginine vasopressin, nicardipine, or nifedipine. The receptors for ET on glomerular mesangial cells suggests a peptide in the regulation of glomerular filtration rate.
responses
vascular
Masanori and
ENDOTHELIN CELLS
1989
recently
have
microcirculatory
SITES FOR MESANGIAL
A. Munger, Schwartzberg,
Medicine and Medicine,
Endothelin contracts glomerular size and ET-specific binding 44.70 nM, and maximal binding sites/cell, at 4OC, stable for binding was observed angiotensin peptide, presence of specific major role for this 0 1989 Academic Press. Inc.
We
BINDING GLOMERULAR
the
cells, of for binding
a ET
in
this of
culture.
be
addressed.
paper: factor: calcium
776
ANF; arginine concentration:
vasopressin: [Ca++li;
AVP; inositol-
BIOCHEMICAL
Vol. 161, No. 2, 1989
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Mesangial
Cell Culture: Rat mesangial cells were isolated and cultured as described previously (1). Briefly, kidneys were excised from two young Sprague-Dawley rats under sterile conditions, and the cortices removed, minced, and washed several times in Hank's Balanced Salt Solution, containing 10 mM HEPES pH 7.4, amphotericin (0.25 pg/ml), and gentamicin (50 pg/ml). The tissue was then passed through consecutive sterilized stainless mesh filters with pore sizes of 212 p, 150 m, and then onto the final mesh of 75 pun. The isolated glomeruli were harvested from the surface of the 75 p filter and washed twice with the Hank's Media. The glomeruli were suspended in RPMI 1640 Medium with 15% Fetal Bovine Serum (Gibco), penicillin (100 U/ml) and streptomycin (100 pg/ml) (Gibco), plated into 100 mm cell culture petri dishes, and incubated at 31' C in a humidified atmosphere of 95% air and 5% C02. Mesangial cell colonies were subcultured in 24-well plates, and experiments were carried out on cells from passages 3 or 4. Criteria used to establish the identity of mesangial cells have been established previously The mesangial cells were routinely grown in RPMI-1640, supplemented with (1). 15% fetal calf serum, penicillin 100 U/ml, and streptomycin 100 pg/ml. Iodination of Endothelin: Synthetic porcine ET was radioiodinated by the lactoperoxidase method (3). ET (2.5 1.19 in 10 1.11 of 0.015% Triton-X305) was mixed with 30 1.11 of 0.5 M sodium phosphate, pH 1.0, and 0.7 mCi of carrier free [lz51]-NaI (4.8 wl). The reaction was started by adding lactoperoxidase pg/ml) and Hz02 (10 ~1, 0.003%). After I to 10 min at room (10 1.11, 17.5 temperature, the reaction was stopped by adding 100 ~1 of 1% BSA/O.l% trifluoroacetic acid. Iodinated ET was separated from ET and free iodide by HPLC on a Vydac Cl8 column with a linear gradient of acetonitrile (20-80s) containing 0.1% trifluoroacetic acid at a flow rate of 1 ml/min. Specific activity of iodinated ET used was 1263 Ci/rmnol or 1579 Ci/mmol. [lz51]-ET Binding Studies: Studies of [125I]-ET binding were performed on mesangial cells grown to confluence in 24-well cluster dishes. Experiments were performed in a buffer consisting of RPMI 1640 with 0.1% BSA. Binding studies were routinely performed at 4O C. Cells were washed once with buffer and then exposed to the appropriate concentration of L~~~II-ET in buffer. At the completion of the experiment, the experimental medium was removed and the cells were washed 5 times with ice cold buffer. The cells were then dissolved with 1.0 ml of 1.0 N NaOH overnight, then tranferred to small tubes for determination of the bound radioactivity using a gamma counter (Beckman Gamma 4000). Non-,specific binding was determined by measuring the amount of [125~]ET bound in the presence of 1000 fold excess of unlabeled ET. Cell density was determined by counting cells from replicate wells, USing a Coulter Counter ZBi (Coulter Electronics, Inc., Hialeah, Fla.) . The time course of specific [125I]-ET binding to mesangial cells was assessed in 2 experiments in which 25 pM [125I]-ET was incubated with mesangial cells as described above and specific binding assessed at 10, 30, 60, 90, 120 and 180 min following addition of the agonist. To dete.rmine the affinity and density of ET-binding sites, mesangial cells [125~]-~~ in were incubated with 25 pM the presence of increasing concentrations (0.01 to 500 nM) of cold ET (n=4 experiments, each concentration of which was performed in duplicate). Specific binding was determined for each concentration, and values for the dissociation constant (Kd) and maximal binding capacity (Bmax) calculated using Scatchard analysis (4). Competitive binding-inhibition studies were carried out by incubation of mesangial cells with 25 pM [125I]-ET and addition, at equilibrium, of lOOOfold concentrations of ANF, AVP, AII, nicardipine, and nifedipine.
Time-course As cells following
of
shown
in
increased addition
[~~~II-ET Figure
1,
Binding specific
progressively of
the
at binding
with agonist,
4OC: of
time, and
777
25
pM
[125I]-ET
reaching remained
a stable
to
rat
maximum for
mesangial at
up
to
120 180
min min.
Vol.
161,
No.
2, 1989
BIOCHEMICAL
0
AND
30
60
BIOPHYSICAL
90
RESEARCH
120
150
COMMUNICATIONS
180
Time (min) Figure mesangial Squares: specific
1:
Time cells. Total Binding.
Nonspecific
dependent Binding Binding; Values
binding
stable
reached
thereafter.
reversed
by
addition
2 depicts ET
increasing
by the
nM).
absence AVP,
of or
and
at
remained
relatively
equilibrium
of ET (Figure
excess
inhibition
Binding
of
of
cold
nM
each),
competitive
AI1
(25 pM) binding to rat 120 min. Symbols; Open Binding: Diamonds: Non-
10 min
binding
lOOO-fold
percent
concentrations
of ANF,
a
at
was
totally
2).
Parameters: the
(0.01-500
at
maximum
[12511-ET of
Binding
Figure
its
Specific
the
Equilibrium cold
increase in [12511-ET equilibrium was reached Closed Squares: Specific are means k SEM.
(500
ET
binding
of
[lz5
II-ET
and
was
upon nicardipine
binding
of
25
decreased highly
pM
specific,
addition
[12511-ET
by
progressively
with
as
of excess
demonstrated
concentrations
or nifedipine
(100
nM, each).
loo? 5 c
80-
z
60-
Li +
40-
ANF AVP All
g
20-
Nit Nit
8 .OOl 01
0
2
.I .T I 1
O-1
.
~
”
0
I
[&d
1’0
1 do
A$onisf] (nM)
Id00
.-
. 2
I 3
lob00
B (fmol/lO
Figure 2: Percent binding of 25 pM [ 1251]-ET in the presence concentrations (on log scale) of cold ET (closed squares) agents. Note the reversibility of binding by ET and its total presence of other tested agents. Values are means f SEM. Figure presence of 0.76 binding
.
3:
Scatchard transformation of the data in Figure 2, of two separate binding sites for ET on rat mesangial (ER-1) and 44.70 nM (ER-21, and Bmax values of 6.713~10~ sites/cell, respectively. 778
6cells)
of increasing (n=41 and other absence in the revealing the cells with Kds and 27.60~102
L 4
Vol. 161, No. 2, 1989 Transformation
of
presence
of
Bmax Kd
of
44.70
(ER-2)
nM
data
classes
of
binding
sites
and
(Figure
In
the
two
6.8~10~
of
BIOCHEMICAL
The
described
The
physiologic
close
to
membranes
was
concentrations
by
to
EGTA.
colleagues
seems
of reasonable
ET
the
a
studies, in
less to
than advance
the
papillary
our
whole
779
stores
followed
by
to
1 nM,
together that
however, by
maximal by in
was
higher rat
as
of well was
ET
mesangial
with mesangial
of
our
for
whereas [Ca++]i as not present cell
a
values
maintained
(EGTA),
contraction
Taken
by
characterized
spike (l),
to was
concentrations
which
studies
cells generation
lower
picomolar
inositol
followed
subsequently
transient
hypothesis
of
elicited
Ca"
cell 1 nM.
is
(spike
was with
[Ca+']i
onset in
nM)
from
InsP3
0.1
signal
extracellular
mesangial
renal
mesangial
The
course
response reported
Furthermore,
nM.
plateau,
were
rapid
the
0.76
stimulation
concentrations
those
of
are
addition,
determined
intracellular
calcium
increase
in
(5),
ET
spike
In
removal
resulted
concentrations it
(4).
which
(1.2,s)
In
rat
of
10 time
of
and
sustained
abolished
Its
i.
a sustained
results al
putative at
(ET-~,
that
exposure than
At
the
of
bound
these
cells
for
The
membrane
here.
(61
the
cells.
of
these
ET-induced
greater
(1).
al
half
release
in
et
et
demonstrate these
site
of
nM).
[Cat+1
noted,
Similar
slow
Martin
upon
or
to
in
the
presence
concentrations
reported
demonstrated
to
we
that
the
in
intracellular
presence
observed
approximately
Ca++
Simonson a
by
in
obtained
insensitive
a
phosphate
the
on
binding
(1.3
equal
increase
those
and
and site
endothelin inositol
suggests
constants
suggested
gradual
been
for
Here,
the
affinity
we
extracellular
stimulated
a
transduction
concentration,
since
generation)
ET
generation
by
further
have
and
increases
concentrations.
and
nM)
plateau)
cells,
binding
reported
(InsPs
by
and
(ER-1)
and
affinity
signal
[12511-ET
suggest
high
studies,
of
InsP3
the
nM
0.76
low
include
cells.
binding
preparations
previous
turnover
than
min
the
(0.66
accompanied
slow
ET
that
membrane
of
the
actions
for
dissociation
the
close
influx
of
suggesting
these
relevant,
the
for
concentrations
no
of
to
to
Kd
sustained
with
site
for
cells
sites
biologically
responses
lipid
Kd
responses,
contraction,
on
[ 12511-ET
affinity
are
our
consistent
affinity
cell
calcium
and
binding
of
glomerular
high
per
mesangial
receptors
strikingly
the
was
apparent
systemic
intracellular
specific
receptors.
In
in
in
characteristics
of
an
cellular and
responses
of
remarkably
for sites
glomerular,
mitogenesis,
receptors
method with
cell
we
endothelin-specific
cell
per
(l),
elevations
presence
sites
27.6~10'
cellular
alkalinization,
value
binding
of
renovascular,
rat.
Scatchard
a Bmax
studies
turnover,
the
3)
recent
pathways,
by
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ET 20
higher which
was
of
Dunn
those observed
findings, contraction
at
Vol. 161, No. 2, 1989
in
response
to
resulting
from
affinity,
higher
presence
of
ET,
extracellular
nature
of
(ER-1)
ER-1,
in
may
responses
to blockers
(1,2,5,7,8).
findings
is
identify the
three
human
ET
subtypes.
If
mesangial
cells
report
structurally
may
in
to
fact
Inoue
The
existence
discrepancy contractile
with et
al
the
of
in
we
for
to
which
our these
isopeptides
multiple
subtypes
receptors
respect
(9) distinct
existence
rat,
represent
affinity
apparent
interest
the
the
higher
ET-induced
pharmacologically
suggest
applies
(1,2,5).
dihydroperidine-sensitive-calcium-
by
and
and
same
the of
particular
recent
family
the
for
to
ET-stimulated
defined.
sensitivity
the and
cells
the
incompletely
lower on
nicardipine
these
by
the
i
ET
have
receptor
identified
distinct
forms
on of
ET
in
species. The
by
Of
the
in
[Cat+1
dependent
transduce
evoked
and
of
not by
to
explanation
in
activation
hence
responses
the
calcium
present authors
an
the
appears
remains
regarding
increases
inhibitable
responses
provide
channel
not
also
cells
extracellular
of and
mitogenic
biologic
reports
rapid
(ER-2)
and
and
mesangial
however, published
site
site
the
through
a consequence
Ca++
alkalinization
receptor
this
is binding
receptor
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
mediated
release,
This
The
for
is
density
intracellular
among
which
InsPs
nifedipine.
of
BIOCHEMICAL
total
ANF,
absence
A II,
during
and
nicardipine
fact
identical In
a
a calcium
we
have
transduces
including
These glomerular
We
described
function, may
evidence
be
of
a
of of
for
(ER-2)
cells.
suggest
their
lack
either
to
mesangial
cells
respective
competition
the
ET
receptors by
binding
nifedipine sites
is
in
channel. the
binding
propose
that
functional
regulatory
and relevance
the responses
of
for low
for
affinity to
model
endothelin
provide
a
in
endothelin-responsive
for
a high
affinity
endothelin
on site
endothelin
alkalinization,
role
other
existence sites
intracellular
contraction,
data
binding of
the that
provided
previously
cells,
activation
unlikely
affinity
mesangial
[ 1251]-ET
Furthermore, it
to
low
for
against
responses.
and
glomerular
competition
argues
makes
summary,
(ER-1)
which
AVP
ET-evoked
and
of
in
(ER-2) in
these
and
mitogenesis.
the
control
agonist-receptor
rat
of
interactions cells.
ACKNOWLEDGMENTS
This
work
and
HL35323
was
supported
by
NIH
Grants
DK38667
and
DK39261
(KFB)
and
HL14192
(TI).
REFERENCES 1. Badr, K. F., Murray, J. J. Breyer, M. D., Takahashi, K., Inagami, T. and Harris, R. C. (1989) J. Clin. Invest. 83:336-342. 2. Simonson, M. S., Wann, S. Mene, P., Dubyak, G. R., Kester, M., Nakazato, Sedor, J. R., and Dunn, M. J. (1989). J. Clin. Invest. 83:708-712. Y., 3. Hirata, Y. Yoshimi, H., Takata, S., Watanabe, T. X., Kumagi, S., Nakajima, K ., and Sakakibara, S. (1988) Biochem. Biophys. Res. Commun. 154:868-875.
780
Vol. 161, No. 2, 1989
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
4. Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51:660-672. 5. Dunn, M. J., Wolfe, J. A., and Simonson, M. S. (1989) Clin. Res. 37:489A. 6. Martin, E. R., Brenner, B. M., and Ballermann, B. J. (1989) Kidney Int. 35:316. 7.
Yanigasawa, M., Kurihara, H., Kimura, S., Tomobe,Y., Koboyashi,M., Mitsui,Y., Goto, K. and Masaki,T. (1988) Nature. 332:411-415. 8. Brain, S. D., Tippins, J. R., and Williams, T. J. (1988) Br. J. Pharmacol. 95: 1005-1007. 9. Inoue, A., Yanigasawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., Proc. Nat'l. Acad. Sci. U.S.A. 86:2863-2867. and Masaki, T. (1989).
781